Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
23 June, 2017 19:25 IST
Piramal Enterprises concludes acquisition of drug portfolio from Mallinckrodt
Source: IRIS | 20 Mar, 2017, 10.28AM
Comments  |  Post Comment

Piramal Enterprises, one of India's largest diversified companies with a presence in pharmaceutical, financial services, announced that its wholly owned Critical Care subsidiary in the UK has completed its acquisition of a portfolio of drugs for spasticity and pain management from Mallinckrodt LLC (Mallinckrodt).

As indicated in the Press Release dated January 30, 2017, the acquisition was for a cash consideration of USD 171 million and up to an additional USD 32 million payable depending on financial performance of the acquired assets over the next three years.

The portfolio acquired includes Gablofen (baclofen), a severe spasticity management product, which is currently marketed in the United States, and two pain management products, which are currently under development. Gablofen has also been approved for launch in eight European markets.

Gablofen is the only intrathecal baclofen drug available in vials and pre-filled syringes, which are preferred by users over the competing products available in ampoules. The pain management drugs under development are also for intrathecal administration. In the twelve months ending September 30, 2016, the acquired portfolio generated revenues of USD 44.6 million.

Shares of the company gained Rs 9.25, or 0.5%, to trade at Rs 1,871.90. The total volume of shares traded was 217 at the BSE (10.17 a.m., Monday).



Piramal Enterprises Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Piramal Enterprises gets nod to raise up to Rs 1.25 bn - 23-Jun-2017 16:00
Bajaj Finance raises Rs 6 bn through issue of NCDs - 23-Jun-2017 11:04
ABAN Offshore arm bags order from Brunei Shell Petro for 5 years - 23-Jun-2017 10:47
Wockhardt settles ongoing commercial litigation with Teva - 23-Jun-2017 10:34
EID Parry's division forges partnership with Synthite Ind - 23-Jun-2017 10:28
Shriram EPC secures multiple orders worth Rs 1.65 bn - 23-Jun-2017 09:41
Wipro collaborates with Red Hat for cloud application factory - 23-Jun-2017 09:20
Reliance Defence to partner with Daher for aerospace components - 23-Jun-2017 09:16
Strides Shasun, Vivimed Labs achieve closure to set up JV in India, Singapore - 22-Jun-2017 14:26
PI Industries enters into JV agreement with Kumiai Chemical - 22-Jun-2017 14:22
Lupin launches generic Topicort LP Emollient Cream, Topicort cream in US - 22-Jun-2017 14:17
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer